Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 39Breast 20Genitourinary 17Thoracic 16Head & Neck 12Gynecologic 4Dermatologic 3Sarcoma 2NET 1Endocrine 1Classical hematology 1CNS 1

Conditions

Neuroendocrine Tumors 130Gastro-enteropancreatic neuroendocrine tumor 16Pancreatic Neoplasms 14Neoplasms 12Stomach Neoplasms 8Carcinoma, Neuroendocrine 8Carcinoid Tumor 8Prostatic Neoplasms 7Lung Neoplasms 7Carcinoma, Hepatocellular 7Breast Neoplasms 7Thyroid Neoplasms 6Melanoma 6Esophageal Neoplasms 6Colonic Neoplasms 6Rectal Neoplasms 5Pheochromocytoma 5Neoplasm Metastasis 5Gastrointestinal Stromal Tumors 5Carcinoma 5Adenoma, Islet Cell 5Adenocarcinoma 5Testicular Neoplasms 4Skin Neoplasms 4Serotonin Syndrome 4Sarcoma 4Paraganglioma 4Liver Neoplasms 4Kidney Neoplasms 4Head and Neck Neoplasms 4

Interventions

lanreotide 1Sorafenib 1Radiofrequency Ablation 1Octreotide 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Neoplastic Cells, Circulating × NET × Clear all
NCT02973204 2021-04-28

Circulating Tumor Cells and Tumor DNA in HCC and NET

University of Aarhus

Completed
167 enrolled
EndocrineGastrointestinalNET

Carcinoma, Hepatocellular, Neoplastic Cells, Circulating, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡